Karl K - Search Results

1

Reduced retinal vessel response to flicker stimulation but not to exogenous nitric oxide in type 1 diabetes.

Pemp B, Garhofer G, Weigert G, Karl K, Resch H, Wolzt M, Schmetterer L. Pemp B, et al. Among authors: karl k. Invest Ophthalmol Vis Sci. 2009 Sep;50(9):4029-32. doi: 10.1167/iovs.08-3260. Epub 2009 Apr 15. Invest Ophthalmol Vis Sci. 2009. PMID: 19369238 Clinical Trial.

2

Effect of unspecific inhibition of cyclooxygenase by indomethacin on retinal and choroidal blood flow.

Weigert G, Berisha F, Resch H, Karl K, Schmetterer L, Garhofer G. Weigert G, et al. Among authors: karl k. Invest Ophthalmol Vis Sci. 2008 Mar;49(3):1065-70. doi: 10.1167/iovs.07-0824. Invest Ophthalmol Vis Sci. 2008. PMID: 18326731 Clinical Trial.

3

Effect of dual endothelin receptor blockade on ocular blood flow in patients with glaucoma and healthy subjects.

Resch H, Karl K, Weigert G, Wolzt M, Hommer A, Schmetterer L, Garhöfer G. Resch H, et al. Among authors: karl k. Invest Ophthalmol Vis Sci. 2009 Jan;50(1):358-63. doi: 10.1167/iovs.08-2460. Epub 2008 Aug 21. Invest Ophthalmol Vis Sci. 2009. PMID: 18719081

4

Correlation of flicker-induced and flow-mediated vasodilatation in patients with endothelial dysfunction and healthy volunteers.

Pemp B, Weigert G, Karl K, Petzl U, Wolzt M, Schmetterer L, Garhofer G. Pemp B, et al. Among authors: karl k. Diabetes Care. 2009 Aug;32(8):1536-41. doi: 10.2337/dc08-2130. Epub 2009 May 28. Diabetes Care. 2009. PMID: 19478197 Free PMC article.

5

Effects of antioxidants (AREDS medication) on ocular blood flow and endothelial function in an endotoxin-induced model of oxidative stress in humans.

Pemp B, Polska E, Karl K, Lasta M, Minichmayr A, Garhofer G, Wolzt M, Schmetterer L. Pemp B, et al. Among authors: karl k. Invest Ophthalmol Vis Sci. 2010 Jan;51(1):2-6. doi: 10.1167/iovs.09-3888. Epub 2009 Aug 13. Invest Ophthalmol Vis Sci. 2010. PMID: 19684008 Clinical Trial.

6

Effect of systemic moxaverine on ocular blood flow in humans.

Resch H, Weigert G, Karl K, Pemp B, Garhofer G, Schmetterer L. Resch H, et al. Among authors: karl k. Acta Ophthalmol. 2009 Nov;87(7):731-5. doi: 10.1111/j.1755-3768.2008.01338.x. Epub 2008 Sep 5. Acta Ophthalmol. 2009. PMID: 18778333 Free article. Clinical Trial.

7

Quantitative and qualitative differences in the activation of a fibroblast growth factor receptor by different FGF ligands.

Krzyscik MA, Karl K, Dudeja P, Krejci P, Hristova K. Krzyscik MA, et al. Among authors: karl k. Cytokine Growth Factor Rev. 2024 Aug;78:77-84. doi: 10.1016/j.cytogfr.2024.07.002. Epub 2024 Jul 9. Cytokine Growth Factor Rev. 2024. PMID: 39043538 Review.

8

Identifying physical therapists' attitudes, beliefs, and barriers toward diagnostic imaging referral: a mixed-methods study.

Schumacher MR, Karl KA, Stich MA, Dean CR, Lawson SR, Hogan JL. Schumacher MR, et al. Among authors: karl ka. J Man Manip Ther. 2024 Oct;32(5):506-514. doi: 10.1080/10669817.2024.2346957. Epub 2024 Apr 27. J Man Manip Ther. 2024. PMID: 38676667 Free article.

9

Ligand bias underlies differential signaling of multiple FGFs via FGFR1.

Karl K, Del Piccolo N, Light T, Roy T, Dudeja P, Ursachi VC, Fafilek B, Krejci P, Hristova K. Karl K, et al. Elife. 2024 Apr 3;12:RP88144. doi: 10.7554/eLife.88144. Elife. 2024. PMID: 38568193 Free PMC article.

10

Ovarian stimulation with excessive FSH doses causes cumulus cell and oocyte dysfunction in small ovarian reserve heifers.

Karl KR, Schall PZ, Clark ZL, Ruebel ML, Cibelli J, Tempelman RJ, Latham KE, Ireland JJ. Karl KR, et al. Mol Hum Reprod. 2023 Sep 30;29(10):gaad033. doi: 10.1093/molehr/gaad033. Mol Hum Reprod. 2023. PMID: 37713463 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

98 results

Search Page

Filters